Ohtuvayre Suspension
Product Images NDC 83034-003

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ohtuvayre (NDC 83034-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ensifentrine 01)

Chemical structure of ensifentrine showing its molecular arrangement with labeled rings and functional groups consistent with the active ingredient in the Ohtuvayre inhalation suspension product.*

FDA Label Image

Figure 1 (Ensifentrine 02)

A line graph comparing the mean change from baseline FEV1 (in mL) over post-dose time points ranging from 30 minutes to 12 hours. It shows data for Ohtuvayre and placebo, with Ohtuvayre demonstrating a higher increase in FEV1 initially, peaking around 1 hour, and then gradually declining over time compared to placebo.*

FDA Label Image

Image (Ensifentrine 03)

An illustration of a single-dose ampule, showing the shape and design typically used for liquid medication, with a narrow tip for breaking to access the suspension inside.*

FDA Label Image

Figure A (Ensifentrine 04)

An instructional diagram labeled Figure A shows hands removing an ampule from its pouch. The ampule is clearly identified in the image, demonstrating the step of taking the ampule out of its protective packaging.*

FDA Label Image

Figure B (Ensifentrine 05)

Illustration showing a hand holding a small container or inhalation device, demonstrating the action of shaking it vigorously back and forth as indicated by an arrow and the accompanying text 'Shake vigorously.' This likely instructs on proper preparation before use of Ohtuvayre suspension for inhalation.*

FDA Label Image

Figure C (Ensifentrine 06)

An instructional diagram labeled 'Figure C' showing two hands demonstrating how to twist open the top of an ampule. The image includes an arrow indicating the twisting motion needed to open the ampule.*

FDA Label Image

Figure D (Ensifentrine 07)

An instructional diagram showing a hand holding an ampule, preparing to dispense liquid into the open reservoir (nebulizer cup) of a nebulizer device. The parts labeled include the ampule, nebulizer cup (reservoir), and nebulizer, illustrating the process of adding suspension medication for respiratory inhalation.*

FDA Label Image

Figure E (Ensifentrine 08)

An instructional diagram labeled 'Figure E' showing components of a respiratory inhalation device. It depicts the device with a detachable mouthpiece, indicated by an arrow pointing to the mouthpiece being removed from the main body of the inhaler.*

FDA Label Image

Figure F (Ensifentrine 09)

An instructional diagram showing the assembly of a nebulizer system for respiratory inhalation. It labels the components including the compressor, tubing, nebulizer, and mouthpiece, with arrows indicating the tubing connection between the compressor and nebulizer and the flow direction from nebulizer to mouthpiece.*

FDA Label Image

Figure G (Ensifentrine 10)

An instructional illustration showing a person using a respiratory inhalation device. The figure highlights the user holding the inhaler with one hand while placing the mouthpiece in the mouth and breathing in. A clock icon indicates to continue inhaling for 5 to 7 minutes.*

FDA Label Image

Principal Display Panel (3 mg/2.5 mL Ampule Carton)

Packaging label for Ohtuvayre 3 mg/2.5 mL inhalation suspension (ensifentrine) by Merck Sharp & Dohme LLC. The label indicates the product is for oral inhalation only and contains 60 unit-dose ampules. It includes storage instructions, NDC 83034-003-60, and prescription-only designation (Rx Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.